Bioventus Inc. Profile Avatar - Palmy Investing

Bioventus Inc.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain trea…

Medical - Devices
US, Durham [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Bioventus Inc. has no acquisition track records yet.

M&A Deals · History

Bioventus Inc. has no acquisition track records yet.

M&A Deals · Within Industry

Keep an eye on latest M&A deals done inside the None Industry.

Details
UMB Financial Corporation
Equity
Agg. Maximum Price
$1,926,470,000.00
Details
?
Equity
Agg. Maximum Price
$997,170,962.65
Details
?
Equity
Agg. Maximum Price
$1,590,231,912.00
Details
?
Equity
Agg. Maximum Price
$25,679,772.00
Details
?
Equity
Agg. Maximum Price
$n/a
?
Details
?
Equity
Agg. Maximum Price
$16,662,212.53
Details
?
Equity
Agg. Maximum Price
$48,186,704.00
?
Details
First Advantage Corporation
Equity
Agg. Maximum Price
$318,310,423.50
Details
?
Equity
Agg. Maximum Price
$78,285,358.86
Details
?
Common
Agg. Maximum Price
$15,519,353.00

M&A Deals · Latest

Act, dont react; Track the most urgent M&A deals across all industries

Details
Owens Corning
Debt
Agg. Maximum Price
$373,155,000.00
Details
?
Equity
Agg. Maximum Price
$n/a
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
?
Equity
Agg. Maximum Price
$2,264,484.00
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
?
Equity
Agg. Maximum Price
$381.73
Details
?
Equity
Agg. Maximum Price
$7,657,428.54
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
?
Equity
Agg. Maximum Price
$19,377,844.50
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00
End of BVS's Analysis
CIK: 1665988 CUSIP: 09075A108 ISIN: US09075A1088 LEI: - UEI: -
Secondary Listings
BVS has no secondary listings inside our databases.